|
Originally published In Press as doi:10.1074/jbc.M309063200 on January 5, 2004
J. Biol. Chem., Vol. 279, Issue 12, 11408-11416, March 19, 2004
Akt Is a Neutral Amplifier for Th Cell Differentiation*
Yutaka Arimura ,
Fumiko Shiroki ¶,
Shingo Kuwahara ,
Hidehito Kato ,
Umberto Dianzani||,
Takehiko Uchiyama , and
Junji Yagi
From the
Department of Microbiology and Immunology, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan and the ||Interdisciplinary Research Center of Autoimmune Diseases (IRCAD) and Department of Medical Sciences, A. Avogadro University of Eastern Piedmont, Novara 28100, Italy
Both CD28 and its relative, inducible costimulator (ICOS), have a binding motif for phosphatidylinositol 3-kinase (PI3K) in their cytoplasmic tail, and the binding of PI3K leads to activation of a serine/threonine kinase, Akt. The role of Akt in cytokine production and helper T (Th) cell differentiation remains obscure. In this study, we found that enforced expression of the constitutively active form (E40K) of Akt rendered CD4+ T cells activated. Wild-type of Akt and E40K promoted Th1 cell differentiation in C57BL/6-derived and Th1-polarized BALB/c-derived CD4+ T cells, while both promoted Th2 cell differentiation in BALB/c-derived and Th2-polarized C57BL/6 CD4+ T cells. E40K also facilitated Th1 differentiation in CD4+ T cells from IL-4-deficient mice with the BALB/c background. E40K up-regulated expression of NF-AT and c-Myb, which may be related to the augmentation of cytokine production by E40K. These findings indicate that the mechanism by which Akt augments cytokine production via CD28 and ICOS is Th cell type-specific and reflects the intracellular status affected by the cytokine milieu. We conclude that Akt is a neutral amplifier of T cell activation and Th differentiation.
Received for publication, August 15, 2003
, and in revised form, December 4, 2003.
* This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan; the Ministry of Public Welfare of Japan; the research fund of professor emeritus Dr. Kiyoko Kurokawa; and the Associazione Italiana Ricerca sul Cancro (AIRC, Milan, Italy). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Present address: Microbiology and Immunology, Keio University School of Medicine, Tokyo 160-8582, Japan.
To whom correspondence and reprint requests should be addressed: Dept. of Microbiology and Immunology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. Tel: 81-3-3353-8111; Fax: 81-3-5269-7411; E-mail: arimura{at}research.twmu.ac.jp.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Ji, F. Rintelen, C. Waltzinger, D. Bertschy Meier, A. Bilancio, W. Pearce, E. Hirsch, M. P. Wymann, T. Ruckle, M. Camps, et al.
Inactivation of PI3K{gamma} and PI3K{delta} distorts T-cell development and causes multiple organ inflammation
Blood,
October 15, 2007;
110(8):
2940 - 2947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Crellin, R. V. Garcia, and M. K. Levings
Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells
Blood,
March 1, 2007;
109(5):
2014 - 2022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Shiroki, S. Matsuda, T. Doi, M. Fujiwara, Y. Mochizuki, T. Kadowaki, H. Suzuki, and S. Koyasu
The p85{alpha} Regulatory Subunit of Class IA Phosphoinositide 3-Kinase Regulates beta-Selection in Thymocyte Development
J. Immunol.,
February 1, 2007;
178(3):
1349 - 1356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Okkenhaug, D. T. Patton, A. Bilancio, F. Garcon, W. C. Rowan, and B. Vanhaesebroeck
The p110{delta} Isoform of Phosphoinositide 3-Kinase Controls Clonal Expansion and Differentiation of Th Cells
J. Immunol.,
October 15, 2006;
177(8):
5122 - 5128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Watanabe, Y. Hara, K. Tanabe, H. Toma, and R. Abe
A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets
Int. Immunol.,
March 1, 2005;
17(3):
269 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Watanabe, S. Watanabe, Y. Hara, Y. Harada, M. Kubo, K. Tanabe, H. Toma, and R. Abe
ICOS-Mediated Costimulation on Th2 Differentiation Is Achieved by the Enhancement of IL-4 Receptor-Mediated Signaling
J. Immunol.,
February 15, 2005;
174(4):
1989 - 1996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-i. Tsukumo and K. Yasutomo
Notch Governing Mature T Cell Differentiation
J. Immunol.,
December 15, 2004;
173(12):
7109 - 7113.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|